Techbio combining quantum-inspired physics and generative AI for drug discovery.
| Date | Round | Amount |
|---|---|---|
| Dec 2024 | Funding round Paris-based AQEMIA raised an additional 38M USD led by Cathay Innovation to advance its AI drug-discovery platform toward clinical trials. | $38M |
| Feb 2024 | Series A Paris pharma-tech Aqemia raised an additional €30M (bringing its Series A to €60M) led by Wendel Growth for its GenAI/quantum drug discovery. | $32.4M |
| Oct 2022 | Series A French drug discovery company Aqemia raised a EUR30M Series A led by Eurazeo and Bpifrance Large Venture, with Elaia. | $30M |